Procter & Gamble Health Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Procter & Gamble Health Limited generated cash of $2,282,800,000, which is less than the previous year. Cash used in financing activities reached the amount of -$4,181,100,000 last year. Net change in cash is therefore -$1,966,900,000.
Cash Flow
| 2013 | 4.5M | 70.4M | -48.2M |
|---|---|---|---|
| 2014 | 49.5M | 105.7M | -166.2M |
| 2015 | 836.6M | -680.3M | -119.2M |
| 2016 | 1.07B | -749.7M | -149.8M |
| 2017 | 536.6M | -476.3M | -219.8M |
| 2018 | -1.30B | 12.69B | -300.5M |
| 2020 | 2.95B | 1.04B | -8.83B |
| 2021 | 2.47B | -322.7M | -3.86B |
| 2023 | 2.36B | -215M | -984.7M |
| 2024 | 2.28B | -68.7M | -4.18B |
PGHL.NS Cash Flow Statement (2013 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 4.35B | 3.19B | 6.35B | 11.19B | 103.2M | 262.7M | 91.8M | 54.7M | 65.7M | 39M |
Operating activities | ||||||||||
Net income | 2.00B | 3.14B | 2.33B | 1.69B | 11.37B | 1.52B | 1.10B | 833.3M | 665.6M | 882.5M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 274M | 281M | 300.4M | 192.86M | 249.9M | 264M | 275.5M | 234.2M | 126.8M | 100.7M |
Stock-based compensation expense | 6.9M | 22.4M | 19.3M | 19.7M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 6.9M | 22.4M | 19.3M | 19.7M | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 291.7M | -329.2M | 347M | -292M | -296.2M | -148.3M | 139.9M | -250.4M | -220M | 0 |
Inventories | 231.3M | -323.9M | 152.6M | -207.5M | -280M | 41.3M | -7.9M | 93.6M | -255.2M | -234.3M |
Accounts payable | -716.1M | 639.2M | 18.1M | 354.7M | 269.2M | 91.6M | 95.6M | 0 | 0 | 0 |
Cash generated by operating activities | 2.28B | 2.36B | 2.47B | 2.95B | -1.30B | 536.6M | 1.07B | 836.6M | 49.5M | 4.5M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -1.05B | -3.77B | -9.31B | -10.11B | -9.11B | -8.55B |
Investments In Property Plant And Equipment | -217.3M | -424.8M | -525.8M | -232.7M | -267.2M | -303M | -316.5M | -451.9M | -403.8M | -334.1M |
Acquisitions Net | 1.4M | 47.4M | 12.1M | 3M | 10.52B | 200.7M | 158.5M | 370.2M | -117.3M | 421.8M |
Cash generated by investing activities | -68.7M | -215M | -322.7M | 1.04B | 12.69B | -476.3M | -749.7M | -680.3M | 105.7M | 70.4M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -4.14B | -937.9M | -3.81B | -8.83B | -249M | -182.6M | -124.5M | -99.3M | -142.2M | -41.5M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -48.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -4.18B | -984.7M | -3.86B | -8.83B | -300.5M | -219.8M | -149.8M | -119.2M | -166.2M | -48.2M |
Net Change In Cash | -1.96B | 1.16B | -1.71B | -4.80B | 11.09B | -159.5M | 170.9M | 37.1M | -11M | 26.7M |
Cash at end of period | 2.38B | 4.35B | 4.64B | 6.39B | 11.19B | 103.2M | 262.7M | 91.8M | 54.7M | 65.7M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |